Moreover, EGF-induced cell proliferation was also accelerated by rhIL-17A cotreatment in A549 cells, suggesting that the IL-17A-IL-17RC axis may cooperate with the EGF-EGFR axis to promote proliferation of WT-EGFR NSCLC cells. Here, EGFR is linked to non-small cell lung carcinoma.